The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smith, T. J., Khatcheressian, J., Lyman, G. H., Ozer, H., Armitage, J. O., Balducci, L., Bennett, C. L., Cantor, S. B., Crawford, J., Cross, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4451 · Cited by 1,636
Self-citationMortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
Kuderer, N. M., Dale, D. C., Crawford, J., Cosler, L. E., & Lyman, G. H. (2006) · Cancer · doi:10.1002/cncr.21847 · Cited by 1,176
Self-citationAapro, M. S., Bohlius, J., Cameron, D. A., Lago, L. D., Donnelly, J. P., Kearney, N., Lyman, G. H., Pettengell, R., Tjan-Heijnen, V. C., Walewski, J., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.013 · Cited by 1,090
Self-citationChemotherapy‐induced neutropenia: Risks, consequences, and new directions for its management
Crawford, J., Dale, D. C., & Lyman, G. H. (2004) · Cancer · doi:10.1002/cncr.11882 · Cited by 882
Self-citationKuderer, N. M., Dale, D. C., Crawford, J., & Lyman, G. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8823 · Cited by 720
Self-citationGriggs, J. J., Mangu, P. B., Anderson, H., Balaban, E. P., Dignam, J. J., Hryniuk, W. M., Morrison, V. A., Pini, T. M., Runowicz, C. D., Rosner, G. L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.9436 · Cited by 485
Self-citationImpact of Chemotherapy Dose Intensity on Cancer Patient Outcomes
Lyman, G. H. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0009 · Cited by 383
Self-citationRisk Models for Predicting Chemotherapy-Induced Neutropenia
Lyman, G. H., Lyman, C. H., Agboola, O., & Anc Study Group (2005) · The Oncologist · doi:10.1634/theoncologist.10-6-427 · Cited by 336
Self-citationRisk of mortality in patients with cancer who experience febrile neutropenia
Lyman, G. H., Michels, S. L., Reynolds, M. W., Barron, R., Tomic, K. S., & Yu, J. (2010) · Cancer · doi:10.1002/cncr.25332 · Cited by 246
Self-citationPredicting individual risk of neutropenic complications in patients receiving cancer chemotherapy
Lyman, G. H., Kuderer, N. M., Crawford, J., Wolff, D. A., Culakova, E., Poniewierski, M. S., & Dale, D. C. (2011) · Cancer · doi:10.1002/cncr.25691 · Cited by 235
Self-citationLyman, G. H., Morrison, V. A., Dale, D. C., Crawford, J., Delgado, D. J., & Fridman, M. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000119262 · Cited by 224
Self-citationMcLeod, H. L., Sargent, D. J., Marsh, S., Green, E. M., King, C. R., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Thibodeau, S. N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.7943 · Cited by 216
Crawford, J., Allen, J., Armitage, J., Blayney, D. W., Cataland, S. R., Heaney, M. L., Htoy, S., Hudock, S., Kloth, D. D., Kuter, D. J., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0075 · Cited by 177
Self-citationDose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy
Shayne, M., Culakova, E., Poniewierski, M. S., Wolff, D. A., Dale, D. C., Crawford, J., & Lyman, G. H. (2007) · Cancer · doi:10.1002/cncr.22939 · Cited by 145
Self-citationBaseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
for the ELYPSE study group, Ray-Coquard, I., Borg, C., Bachelot, T., Sebban, C., Philip, I., Clapisson, G., Cesne, A. L., Biron, P., Chauvin, F., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600724 · Cited by 133
Pettengell, R., Bosly, A., Szucs, T. D., Jackisch, C., Leonard, R. C., Paridaens, R., Constenla, M., & Schwenkglenks, M. M. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07514.x · Cited by 109
Self-citationChemotherapy dosing in overweight and obese patients with cancer
Lyman, G. H., & Sparreboom, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.108 · Cited by 98
Self-citationHosmer, W., Malin, J. L., & Wong, M. D. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0821-1 · Cited by 89
Moreau, M., Klastersky, J., Schwarzbold, A. V., Muanza, F., Georgala, A., Aoun, M., Loizidou, A., Barette, M., Costantini, S., Delmelle, M., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn655 · Cited by 83
Vulsteke, C., Lambrechts, D., Dieudonné, A. S., Hatse, S., Brouwers, B. A. H., Brussel, T. V., Neven, P., Belmans, A., Schöffski, P., Paridaens, R., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt008 · Cited by 75
Alexandre, J., Rey, E., Girre, V., Grabar, S., Tran, A., Montheil, V., Rabillon, F., Dieras, V. C., Jullien, V., Herait, P., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl321 · Cited by 66
Rational Selection of Patients for Antibacterial Prophylaxis After Chemotherapy
Cullen, M. H., Billingham, L. J., Gaunt, C. H., & Steven, N. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.7395 · Cited by 62
Days of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients
Scott, S., Stolshek, B. S., Fridman, M., Delgado, D. J., Link, B. K., & Chrischilles, E. A. (2003) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2003.9.s2.15 · Cited by 56
Meyerhardt, J. A., Kwok, A., Ratain, M. J., McGovren, J. P., & Fuchs, C. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.043 · Cited by 54
Shayne, M., Culakova, E., Wolff, D. A., Poniewierski, M. S., Dale, D. C., Crawford, J., & Lyman, G. H. (2009) · Cancer · doi:10.1002/cncr.24560 · Cited by 45
Self-citationSalar, A., Haïoun, C., Rossi, F. G., Dührsen, U., Pettengell, R., Johnsen, H. E., Jaeger, U., Verhoef, G. E. G., Schwenkglenks, M. M., Bacon, P., et al. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.02.002 · Cited by 43
Self-citationPredictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer
Laskey, R. A., Poniewierski, M. S., Lopez, M. A., Hanna, R. K., Secord, A. A., Gehrig, P. A., Lyman, G. H., & Havrilesky, L. J. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.03.015 · Cited by 42
Self-citationPhippen, N. T., Lowery, W. J., Barnett, J. C., Hall, L. A., Landt, C., & Leath, C. A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.07.093 · Cited by 29
Okishiro, M., Kim, S. J., Tsunashima, R., Nakayama, T., Shimazu, K., Shimomura, A., Maruyama, N., Tamaki, Y., & Noguchi, S. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1637-5 · Cited by 25
Hurria, A., Brogan, K., Panageas, K. S., Jakubowski, A. A., Zauderer, M. G., Pearce, C., Norton, L., Howard, J., & Hudis, C. A. (2005) · Drugs & Aging · doi:10.2165/00002512-200522080-00007 · Cited by 18
Effects of Mannose-Binding Lectin Polymorphisms on Irinotecan-Induced Febrile Neutropenia
van der Bol, J. M., de Jong, F. A., van Schaik, R. H., Sparreboom, A., van Fessem, M., van de Geijn, F. E., van Daele, P. L. A., Verweij, J., Sleijfer, S., & Mathijssen, R. H. J. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0033 · Cited by 13
Schwenkglenks, M. M., Bendall, K., Pfeil, A. M., Szabó, Z. R., & Pettengell, R. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.780287 · Cited by 9
Self-citation
Cited by
Smith, T. J., Bohlke, K., Lyman, G. H., Carson, K. R., Crawford, J., Cross, S. J., Goldberg, J. M., Khatcheressian, J. L., Leighl, N. B., Perkins, C. L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.3488 · Cited by 904
Self-citationTaplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K. V., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00374 · Cited by 601
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
van den Boogaard, W. M. C., Komninos, D. S. J., & Vermeij, W. P. (2022) · Cancers · doi:10.3390/cancers14030627 · Cited by 458
Kasi, P. M., & Grothey, A. (2018) · Drugs · doi:10.1007/s40265-018-0909-3 · Cited by 80
Metadata
- Authors
- Lyman, G. H., Abella, E., & Pettengell, R.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 90
- Issue
- 3
- Pages
- 190-199
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2031497779
- Cited by
- 348
- References
- 32
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.